NASDAQ Decliners Watch List: Star Scientific, Inc. (NASDAQ:STSI), Rockwell Medical, Inc. (NASDAQ:RMTI), and Savient Pharmaceuticals, Inc. (NASDAQ:SVNT) Added to Growing Stock Report's NASDAQ Decliners Watch List.

New York, NY -- (SBWIRE) -- 03/20/2013 -- Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding Star Scientific, Inc. (NASDAQ:STSI), Rockwell Medical, Inc. (NASDAQ:RMTI), and Savient Pharmaceuticals, Inc. (NASDAQ:SVNT).

Star Scientific, Inc. (NASDAQ:STSI) a company that engages in the manufacture, distribution, and sale of consumer products and dietary supplements closed down in its previous session (-17.17%) on 6,270,034 shares traded after Star Scientific said it is being investigated by the federal government. Star Scientific, Inc. (NASDAQ:STSI) is currently down (-68.71%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about Star Scientific, Inc. (NASDAQ:STSI)

Rockwell Medical, Inc. (NASDAQ:RMTI) an integrated biopharmaceutical company that engages in the manufacture, sale, and distribution of hemodialysis concentrates/dialysates targeting the end-stage renal disease, chronic kidney disease, and iron deficiency anemia in the United States and internationally closed down in its previous session (-15.87%) on 674,862 shares traded after Rockwell Medical reported its financial results for the three and twelve months ended December 31, 2012. Rockwell Medical, Inc. (NASDAQ:RMTI) is currently down (-67.85%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about Rockwell Medical, Inc. (NASDAQ:RMTI)

Savient Pharmaceuticals, Inc. (NASDAQ:SVNT) operates as a specialty biopharmaceutical company in the United States closed down in its previous session (-14.84%) on 1,951,717 shares traded after Savient Pharmaceuticals reported slower sales growth for its gout drug Krystexxa. Savient Pharmaceuticals, Inc. (NASDAQ:SVNT) is currently down (-75.59%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about Savient Pharmaceuticals, Inc. (NASDAQ:SVNT)

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com